Search hospitals > Illinois > Oak Lawn
Advocate Christ Medical Center
Claim this profileOak Lawn, Illinois 60453
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Heart Failure
Conducts research for Non-Small Cell Lung Cancer
225 reported clinical trials
29 medical researchers
Summary
Advocate Christ Medical Center is a medical facility located in Oak Lawn, Illinois. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Heart Failure, Non-Small Cell Lung Cancer and other specialties. Advocate Christ Medical Center is involved with conducting 225 clinical trials across 314 conditions. There are 29 research doctors associated with this hospital, such as Thomas J. Saphner, Rubina Qamar, Antony Ruggeri, and Sigrun Hallmeyer, MD.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 negative
HER2 positive
2Lung Cancer
Global LeaderStage IV
Stage II
Stage III
Top PIs
Thomas J. SaphnerAurora Saint Luke's Medical Center2 years of reported clinical research
Studies Breast Cancer
Studies Cancer
30 reported clinical trials
68 drugs studied
Rubina QamarAurora Saint Luke's Medical Center5 years of reported clinical research
Studies Breast Cancer
Studies Lung Cancer
24 reported clinical trials
68 drugs studied
Antony RuggeriAurora Cancer Care-Milwaukee West5 years of reported clinical research
Studies Pancreatic Cancer
Studies Colon Cancer
14 reported clinical trials
57 drugs studied
Sigrun Hallmeyer, MDAdvocate Lutheran General Hospital2 years of reported clinical research
Studies Breast Cancer
Studies Cancer
13 reported clinical trials
23 drugs studied
Clinical Trials running at Advocate Christ Medical Center
Lung Cancer
Breast Cancer
Ovarian Cancer
Esophageal cancer
Breast cancer
Cancer
Prostate Cancer
Pancreatic Cancer
Bladder Cancer
Non-Small Cell Lung Cancer
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Chemotherapy + Immunotherapy vs. Immunotherapy
for Advanced Lung Cancer
This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.
Recruiting2 awards Phase 3
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Advocate Christ Medical Center?
Advocate Christ Medical Center is a medical facility located in Oak Lawn, Illinois. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Heart Failure, Non-Small Cell Lung Cancer and other specialties. Advocate Christ Medical Center is involved with conducting 225 clinical trials across 314 conditions. There are 29 research doctors associated with this hospital, such as Thomas J. Saphner, Rubina Qamar, Antony Ruggeri, and Sigrun Hallmeyer, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.